146 related articles for article (PubMed ID: 26024025)
1. The vascular secret of Klotho.
Lewin E; Olgaard K
Kidney Int; 2015 Jun; 87(6):1089-91. PubMed ID: 26024025
[TBL] [Abstract][Full Text] [Related]
2. Differential expression and regulation of Klotho by paricalcitol in the kidney, parathyroid, and aorta of uremic rats.
Ritter CS; Zhang S; Delmez J; Finch JL; Slatopolsky E
Kidney Int; 2015 Jun; 87(6):1141-52. PubMed ID: 25692955
[TBL] [Abstract][Full Text] [Related]
3. Effect of chronic uremia on the transcriptional profile of the calcified aorta analyzed by RNA sequencing.
Rukov JL; Gravesen E; Mace ML; Hofman-Bang J; Vinther J; Andersen CB; Lewin E; Olgaard K
Am J Physiol Renal Physiol; 2016 Mar; 310(6):F477-91. PubMed ID: 26739890
[TBL] [Abstract][Full Text] [Related]
4. KLOTHO methylation is linked to uremic toxins and chronic kidney disease.
Young GH; Wu VC
Kidney Int; 2012 Apr; 81(7):611-2. PubMed ID: 22419041
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of vitamin D receptor activators on vascular calcification in uremic rats.
Mizobuchi M; Finch JL; Martin DR; Slatopolsky E
Kidney Int; 2007 Sep; 72(6):709-15. PubMed ID: 17597697
[TBL] [Abstract][Full Text] [Related]
6. Increased parathyroid expression of klotho in uremic rats.
Hofman-Bang J; Martuseviciene G; Santini MA; Olgaard K; Lewin E
Kidney Int; 2010 Dec; 78(11):1119-27. PubMed ID: 20631679
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D Attenuates Endothelial Dysfunction in Uremic Rats and Maintains Human Endothelial Stability.
Vila Cuenca M; Ferrantelli E; Meinster E; Pouw SM; Kovačević I; de Menezes RX; Niessen HW; Beelen RHJ; Hordijk PL; Vervloet MG
J Am Heart Assoc; 2018 Sep; 7(17):e008776. PubMed ID: 30371149
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D and secreted Klotho: a long-awaited panacea for vascular calcification?
Komaba H; Fukagawa M
Kidney Int; 2012 Dec; 82(12):1248-50. PubMed ID: 23203019
[TBL] [Abstract][Full Text] [Related]
9. Membrane-bound Klotho is not expressed endogenously in healthy or uraemic human vascular tissue.
Mencke R; Harms G; Mirković K; Struik J; Van Ark J; Van Loon E; Verkaik M; De Borst MH; Zeebregts CJ; Hoenderop JG; Vervloet MG; Hillebrands JL;
Cardiovasc Res; 2015 Nov; 108(2):220-31. PubMed ID: 26116633
[TBL] [Abstract][Full Text] [Related]
10. Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients.
Komaba H; Goto S; Fujii H; Hamada Y; Kobayashi A; Shibuya K; Tominaga Y; Otsuki N; Nibu K; Nakagawa K; Tsugawa N; Okano T; Kitazawa R; Fukagawa M; Kita T
Kidney Int; 2010 Feb; 77(3):232-8. PubMed ID: 19890272
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of vitamin D analogs on vascular calcification.
Cardús A; Panizo S; Parisi E; Fernandez E; Valdivielso JM
J Bone Miner Res; 2007 Jun; 22(6):860-6. PubMed ID: 17352647
[TBL] [Abstract][Full Text] [Related]
12. Klotho Prevents NFκB Translocation and Protects Endothelial Cell From Senescence Induced by Uremia.
Buendía P; Carracedo J; Soriano S; Madueño JA; Ortiz A; Martín-Malo A; Aljama P; Ramírez R
J Gerontol A Biol Sci Med Sci; 2015 Oct; 70(10):1198-209. PubMed ID: 25246106
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor 23 accelerates phosphate-induced vascular calcification in the absence of Klotho deficiency.
Jimbo R; Kawakami-Mori F; Mu S; Hirohama D; Majtan B; Shimizu Y; Yatomi Y; Fukumoto S; Fujita T; Shimosawa T
Kidney Int; 2014 May; 85(5):1103-11. PubMed ID: 24088960
[TBL] [Abstract][Full Text] [Related]
14. Effect of Paricalcitol on FGF-23 and Klotho in Kidney Transplant Recipients.
Donate-Correa J; Henríquez-Palop F; Martín-Núñez E; Pérez-Delgado N; Muros-de-Fuentes M; Mora-Fernández C; Navarro-González JF
Transplantation; 2016 Nov; 100(11):2432-2438. PubMed ID: 27467536
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease.
Galitzer H; Ben-Dov IZ; Silver J; Naveh-Many T
Kidney Int; 2010 Feb; 77(3):211-8. PubMed ID: 20016468
[TBL] [Abstract][Full Text] [Related]
16. Clinical trials: cardiovascular benefits of paricalcitol in chronic kidney disease.
Edwards JK
Nat Rev Nephrol; 2014 Dec; 10(12):675. PubMed ID: 25347944
[No Abstract] [Full Text] [Related]
17. Intermedin1-53 attenuates vascular calcification in rats with chronic kidney disease by upregulation of α-Klotho.
Chang JR; Guo J; Wang Y; Hou YL; Lu WW; Zhang JS; Yu YR; Xu MJ; Liu XY; Wang XJ; Guan YF; Zhu Y; Du J; Tang CS; Qi YF
Kidney Int; 2016 Mar; 89(3):586-600. PubMed ID: 26880455
[TBL] [Abstract][Full Text] [Related]
18. Effect of paricalcitol and calcitriol on aortic wall remodeling in uninephrectomized ApoE knockout mice.
Becker LE; Koleganova N; Piecha G; Noronha IL; Zeier M; Geldyyev A; Kökeny G; Ritz E; Gross ML
Am J Physiol Renal Physiol; 2011 Mar; 300(3):F772-82. PubMed ID: 21159735
[TBL] [Abstract][Full Text] [Related]
19. Dual-specificity phosphatases are implicated in severe hyperplasia and lack of response to FGF23 of uremic parathyroid glands from rats.
Román-García P; Carrillo-López N; Naves-Díaz M; Rodríguez I; Ortiz A; Cannata-Andía JB
Endocrinology; 2012 Apr; 153(4):1627-37. PubMed ID: 22334717
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of renal Klotho and FGFR1 in normal and uremic rats.
Muñoz-Castañeda JR; Herencia C; Pendón-Ruiz de Mier MV; Rodriguez-Ortiz ME; Diaz-Tocados JM; Vergara N; Martínez-Moreno JM; Salmerón MD; Richards WG; Felsenfeld A; Kuro-O M; Almadén Y; Rodríguez M
FASEB J; 2017 Sep; 31(9):3858-3867. PubMed ID: 28515153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
